FI964395A0 - Nya erytromycinderivater, förfarande för framställning av dessa och deras användning som läkemedel - Google Patents

Nya erytromycinderivater, förfarande för framställning av dessa och deras användning som läkemedel

Info

Publication number
FI964395A0
FI964395A0 FI964395A FI964395A FI964395A0 FI 964395 A0 FI964395 A0 FI 964395A0 FI 964395 A FI964395 A FI 964395A FI 964395 A FI964395 A FI 964395A FI 964395 A0 FI964395 A0 FI 964395A0
Authority
FI
Finland
Prior art keywords
pharmaceuticals
processes
preparation
erythromycin derivatives
new erythromycin
Prior art date
Application number
FI964395A
Other languages
English (en)
Finnish (fi)
Other versions
FI964395A (sv
FI111263B (sv
Inventor
Constantin Agouridas
Jean-Francois Chantot
Alexis Denis
D Ambrieres Solange Gouin
Martret Odile Le
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI964395A publication Critical patent/FI964395A/sv
Publication of FI964395A0 publication Critical patent/FI964395A0/sv
Application granted granted Critical
Publication of FI111263B publication Critical patent/FI111263B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI964395A 1994-05-03 1996-10-31 Nya erytromycinderivater, förfarande för framställning av dessa och deras användning som läkemedel samt mellanproduktaminer för förfarandet FI111263B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9405368A FR2719587B1 (fr) 1994-05-03 1994-05-03 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
PCT/FR1995/000565 WO1995029929A1 (fr) 1994-05-03 1995-05-02 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (3)

Publication Number Publication Date
FI964395A FI964395A (sv) 1996-10-31
FI964395A0 true FI964395A0 (sv) 1996-10-31
FI111263B FI111263B (sv) 2003-06-30

Family

ID=9462785

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964395A FI111263B (sv) 1994-05-03 1996-10-31 Nya erytromycinderivater, förfarande för framställning av dessa och deras användning som läkemedel samt mellanproduktaminer för förfarandet

Country Status (43)

Country Link
US (2) US5635485A (sv)
EP (1) EP0680967B1 (sv)
JP (4) JP2992540B2 (sv)
KR (1) KR100312267B1 (sv)
CN (2) CN1052984C (sv)
AP (1) AP558A (sv)
AT (1) ATE172203T1 (sv)
AU (1) AU684027B2 (sv)
BG (1) BG63087B1 (sv)
BR (1) BR9507700A (sv)
CA (1) CA2189271C (sv)
CZ (1) CZ293455B6 (sv)
DE (2) DE69505296T2 (sv)
DK (1) DK0680967T3 (sv)
DZ (1) DZ1878A1 (sv)
EE (1) EE03263B1 (sv)
ES (1) ES2122472T3 (sv)
FI (1) FI111263B (sv)
FR (1) FR2719587B1 (sv)
GE (1) GEP19991538B (sv)
HK (1) HK1010732A1 (sv)
HU (2) HU227493B1 (sv)
IL (1) IL113245A (sv)
LU (1) LU90872I2 (sv)
LV (1) LV11739B (sv)
MA (1) MA23534A1 (sv)
MD (1) MD1233C2 (sv)
NL (1) NL300077I1 (sv)
NO (2) NO308853B1 (sv)
NZ (1) NZ285416A (sv)
OA (1) OA10319A (sv)
PL (1) PL182034B1 (sv)
RO (1) RO113350B1 (sv)
RU (1) RU2144036C1 (sv)
SI (1) SI0680967T1 (sv)
SK (1) SK281707B6 (sv)
TJ (1) TJ313B (sv)
TN (1) TNSN95049A1 (sv)
TW (1) TW341573B (sv)
UA (1) UA51618C2 (sv)
WO (1) WO1995029929A1 (sv)
YU (1) YU49235B (sv)
ZA (1) ZA953501B (sv)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6241796A (en) * 1995-06-27 1997-01-30 Takeda Chemical Industries Ltd. 4-acylamino(halogeno) alkyl-quinoline derivatives, their preparation and their use as melatonin agonists
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
EP1291352B1 (en) * 1996-09-04 2005-05-25 Abbott Laboratories 6-O-substituted ketolides having antibacterial activity
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
WO2000017218A1 (en) 1998-09-22 2000-03-30 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2785612A1 (fr) * 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
DE69933897T2 (de) 1998-12-10 2007-03-15 Pfizer Products Inc., Groton Carbamat- und Carbazatketolid-Antibiotika
JP3947360B2 (ja) * 1999-01-27 2007-07-18 ファイザー・プロダクツ・インク ケトリド抗生物質
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) * 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
MXPA01010521A (es) 1999-04-16 2003-08-19 Johnson & Johnson Antibacteriales de cetolidos.
CN1241931C (zh) 1999-04-16 2006-02-15 高山生物科学股份有限公司 大环内酯抗感染药物
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
IL145739A0 (en) * 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
FR2797875B1 (fr) * 1999-08-26 2001-10-19 Hoechst Marion Roussel Inc Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
CN1234718C (zh) 2000-08-22 2006-01-04 巴斯利尔药物股份公司 具有抗细菌活性的新的大环内酯
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
CA2451391A1 (en) * 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
EP1521764A2 (en) 2002-07-08 2005-04-13 PLIVA-ISTRAZIVACKI INSTITUT d.o.o. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
ES2325495T3 (es) 2002-07-08 2009-09-07 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Moleculas hibridas de macrolidos con moleculas anti-inflamatorias esteroideas y no esteroideas.
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
US6916934B2 (en) * 2003-02-11 2005-07-12 Aventis Pharma Deutschland Gmbh Process for preparing pyridine-substituted amino ketal derivatives
ES2552682T3 (es) * 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
CA2523541A1 (en) * 2003-04-25 2004-11-11 Chiron Corporation Novel ketolide derivatives
US20050101548A1 (en) * 2003-09-12 2005-05-12 Xiaodong Lin Antimicrobial derivatives
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
JP5383037B2 (ja) 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法
ES2294733T3 (es) * 2004-04-28 2008-04-01 Alembic Limited Proceso para la preparacion de telitromicina.
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
PL1836211T3 (pl) 2004-12-21 2010-07-30 Pfizer Prod Inc Makrolidy
KR100894967B1 (ko) * 2005-02-08 2009-04-24 가부시키가이샤 무라타 세이사쿠쇼 표면 실장형 부특성 서미스터
FR2882522B1 (fr) 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
WO2006129257A2 (en) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
WO2007049296A2 (en) * 2005-10-28 2007-05-03 Alembic Limited Amorphous form of telithromycin
US20070167382A1 (en) * 2005-11-15 2007-07-19 Nina Finkelstein Crystalline and amorphous forms of telithromycin
US20090075916A1 (en) * 2005-11-23 2009-03-19 Upadhyay Dilip J Use of Macrolide Derivatives for Treating Acne
WO2007060518A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
US20090130225A1 (en) * 2005-11-23 2009-05-21 Anjan Chakrabarti Macrolides derivatives as antibacterial agents
US7595300B2 (en) 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
GB0600238D0 (en) * 2006-01-06 2006-02-15 Sandoz Ag Organic compounds
US8097708B2 (en) * 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
JP2010501541A (ja) 2006-08-24 2010-01-21 ウォックハート リサーチ センター 抗菌活性を有する新規マクロライド及びケトライド
WO2008023383A1 (en) * 2006-08-25 2008-02-28 Alembic Limited Novel process for the preparation of telithromycin
ES2306590B1 (es) * 2006-12-15 2009-08-07 Ercros Industrial,S .A. Formas cristalinas i y ii de telitromicina.
US8293715B2 (en) * 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
EP2689693B1 (en) 2007-09-20 2016-09-14 Herman Miller, Inc. Load support structure
EP2214484A4 (en) * 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
WO2009053259A1 (en) * 2007-10-25 2009-04-30 Sandoz Ag Process for the production of telithromycin
US8299035B2 (en) * 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
CN105616437A (zh) * 2008-10-24 2016-06-01 森普拉制药公司 使用含三唑的大环内酯的生物防御
NZ596628A (en) 2009-05-27 2013-03-28 Ketolide compounds having antimicrobial activity
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
CA2793884C (en) 2010-03-22 2019-09-10 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
DK2571506T3 (en) 2010-05-20 2017-08-28 Cempra Pharmaceuticals Inc PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES
JP6042334B2 (ja) * 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
US9175031B2 (en) 2010-12-09 2015-11-03 Wockhardt Limited Ketolide compounds
AR085286A1 (es) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
CN103619849B (zh) 2011-03-01 2016-05-25 沃克哈特有限公司 酮内酯中间体的制备方法
CN103619863B (zh) 2011-03-22 2016-03-16 沃克哈特有限公司 酮内酯化合物的制备方法
AU2013239696C1 (en) 2012-03-27 2018-11-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN105524132B (zh) * 2014-09-30 2019-07-02 中国医学科学院药物研究所 含有喹啉取代基的红霉素a酮内酯类抗生素衍生物、其制备方法及应用
DE102015201783A1 (de) 2015-02-02 2016-08-04 Friedrich Baur Verfahren zur Herstellung eines Füllstoffs aus Textilfasern sowie Textil mit einem solchen Füllstoff
CN107129514B (zh) * 2016-03-02 2019-12-13 中国医学科学院药物研究所 红霉素a酮内酯类抗生素衍生物、其制备方法及应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
EP0034116A3 (en) * 1980-02-11 1981-09-02 Berlex Laboratories, Inc. N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
US4434174A (en) * 1980-02-11 1984-02-28 Berlex Laboratories, Inc. Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
US4568687A (en) * 1983-02-28 1986-02-04 American Cyanamid Company N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions
ZA84949B (en) * 1983-04-06 1984-09-26 American Cyanamid Co Substituted-n-(2-4-(1h-imidazol-1-yl)alkyl)substituted amides
US4489089A (en) * 1983-04-06 1984-12-18 American Cyanamid Company Substituted N-[ω-(1H-imidazol-1-yl)alkyl]-amides
AU573828B2 (en) * 1984-05-17 1988-06-23 E.R. Squibb & Sons, Inc. Tetrahydronaphthalenols
GB8425104D0 (en) * 1984-10-04 1984-11-07 Ici America Inc Amide derivatives
DE3540376A1 (de) * 1985-11-14 1987-05-21 Bayer Ag Verfahren zur inhibierung der wasserstoffinduzierten korrosion von metallischen werkstoffen
EP0269239B1 (en) * 1986-10-29 1994-06-08 Pfizer Inc. Processes for 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole and the crystalline dihydrochloride trihydrate thereof
DE3930669A1 (de) * 1989-09-14 1991-03-28 Basf Ag Verfahren zur herstellung von uretdiongruppen aufweisenden polyisocyanaten
JP2899028B2 (ja) * 1989-12-01 1999-06-02 協和醗酵工業株式会社 ジベンゾオキセピン誘導体
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5403923A (en) * 1990-11-28 1995-04-04 Taisho Pharmaceutical Co., Ltd. 6-0-methylerythromycin A derivatives
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
TW444018B (en) * 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates

Also Published As

Publication number Publication date
NL300077I1 (nl) 2002-03-01
DE69505296D1 (de) 1998-11-19
AP558A (en) 1996-11-07
HU219599B (hu) 2001-05-28
MX9605208A (es) 1997-09-30
UA51618C2 (uk) 2002-12-16
KR100312267B1 (ko) 2002-06-22
LV11739A (lv) 1997-04-20
JPH0853489A (ja) 1996-02-27
CZ293455B6 (cs) 2004-05-12
HU227493B1 (en) 2011-07-28
HU9603038D0 (en) 1997-01-28
IL113245A0 (en) 1995-07-31
JP3998828B2 (ja) 2007-10-31
CZ321496A3 (en) 1997-08-13
RO113350B1 (ro) 1998-06-30
OA10319A (fr) 1997-10-07
EE03263B1 (et) 2000-04-17
JP4658902B2 (ja) 2011-03-23
US6100404A (en) 2000-08-08
NO2001027I1 (no) 2002-01-28
DK0680967T3 (da) 1999-06-23
DE10299001I1 (de) 2012-07-05
JP2007269810A (ja) 2007-10-18
HK1010732A1 (en) 1999-06-25
AU684027B2 (en) 1997-11-27
IL113245A (en) 1999-11-30
NZ285416A (en) 1997-07-27
FR2719587A1 (fr) 1995-11-10
EP0680967B1 (fr) 1998-10-14
ATE172203T1 (de) 1998-10-15
US5635485A (en) 1997-06-03
NO964654L (no) 1996-11-04
MD1233B1 (en) 1999-05-31
CN1088709C (zh) 2002-08-07
CA2189271C (fr) 2005-12-27
WO1995029929A1 (fr) 1995-11-09
RU2144036C1 (ru) 2000-01-10
CN1052984C (zh) 2000-05-31
YU49235B (sh) 2004-12-31
PL182034B1 (pl) 2001-10-31
YU27095A (sh) 1998-05-15
LV11739B (en) 1997-08-20
DZ1878A1 (fr) 2002-02-17
FR2719587B1 (fr) 1996-07-12
NO308853B1 (no) 2000-11-06
JP2007045847A (ja) 2007-02-22
FI964395A (sv) 1996-10-31
DE69505296T2 (de) 1999-04-22
BG63087B1 (bg) 2001-03-30
BG100951A (en) 1997-08-29
CN1151746A (zh) 1997-06-11
EP0680967A1 (fr) 1995-11-08
HU9904687D0 (en) 2000-03-28
JPH11152296A (ja) 1999-06-08
FI111263B (sv) 2003-06-30
ES2122472T3 (es) 1998-12-16
CN1229082A (zh) 1999-09-22
GEP19991538B (en) 1999-03-05
NO964654D0 (no) 1996-11-04
BR9507700A (pt) 1997-08-19
MA23534A1 (fr) 1995-12-31
SI0680967T1 (en) 1999-02-28
TJ313B (en) 2001-08-06
JP4750755B2 (ja) 2011-08-17
CA2189271A1 (fr) 1995-11-09
TW341573B (en) 1998-10-01
AP9500744A0 (en) 1995-07-31
PL317071A1 (en) 1997-03-03
SK281707B6 (sk) 2001-07-10
JP2992540B2 (ja) 1999-12-20
MD1233C2 (ro) 2000-10-31
LU90872I2 (fr) 2002-03-12
TNSN95049A1 (fr) 1996-02-06
HUT75698A (en) 1997-05-28
ZA953501B (en) 1996-05-02
SK140296A3 (en) 1998-04-08
DE10299001I2 (de) 2012-07-05
AU2449995A (en) 1995-11-29

Similar Documents

Publication Publication Date Title
FI964395A0 (sv) Nya erytromycinderivater, förfarande för framställning av dessa och deras användning som läkemedel
FI963283A (sv) 4-heterocyklyl-substituerade kinazolinderivat, förfaranden för deras framställning och deras användning som kancerläkemedel
FI955913A (sv) Nya erytromycinderivat, förfaranden för deras framställning och deras användning som läkemedel
EE9800265A (et) Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
FI935073A (fi) Nya tiopyranopyrrolderivat, framstaellning av dem och dessa innehaollande farmaceutiska sammansaettningar
FI961056A0 (sv) Nya pärlor för kontrollerad frisättning och farmaceutisk beredning innehållande desamma
EE200200095A (et) Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
FI972646A0 (sv) Piperazinderivat, dessa föreningar innehållande läkemedel, deras användning och förfarande för deras framställning
EE200000037A (et) Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena
FI925946A0 (fi) Nya 2-sackarinylmetylaryl- och -aryloxiacetat anvaendbara som inhibitorer foer proteolytiska ensymer, kompositioner innehaollande dessa och anvaendning av dessa
FI970095A (sv) Nya kemiska föreningar, deras framställning och deras användning som läkemedel
FI945780A0 (sv) Nya biologiskt aktiva eburnameninderivat, farmaceutiska kompositioner innehållande dessa och förfarande för framställning av dessa
EE9800145A (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
FI941914A0 (sv) 2-amino-4-kinolindihydropyridiner, förfaranden för framställning av dessa och användning av dessa
FI901199A0 (fi) Nya steroiddioler, dessa innehaollande farmaceutiska foereningar och foerfarande foer framstaellning av dem.
FI954026A (sv) Nya tetrahydropyranföreningar, förfarande för deras framställning och farmaceutiska kompositioner, som innehåller dessa föreningar
FI950874A0 (sv) Nya polyjodiserade föreningar, förfarande för framställning av dem och dessa innehållande kontrastmedel
FI962994A (sv) Nya leukotrien B4-derivat, förfaranden för deras framställning och deras användning som läkemedel
FI965172A0 (sv) Nya amido-kinoxalindioner, framställning och användning av dem
FI942675A (sv) Nya substituerade oxazinoisokinolinderivat, farmaceutiska kompositioner innehållande dessa och förfarande för framställning av dessa
NO993124D0 (no) Nye erytromycinderivater, fremgangsmÕte for fremstilling av disse samt deres anvendelse som medisiner
FI871479A0 (sv) Förfarande för framställning av derivat av perhydrotiazepin och perhydroazepin, som är användbara som läkemedel
AU653019C (en) New urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
FI905675A0 (fi) Nya leukotrien-b4-derivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI940498A0 (fi) System foer uppsamling, haemtning och mottagning av sorterade sopor

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: HOECHST MARION ROUSSEL

SPCF Supplementary protection certificate application filed

Spc suppl protection certif: L20030009

SPCG Supplementary protection certificate granted

Spc suppl protection certif: NUMBER:214

MA Patent expired